UC BON.CAP.CERT. 03/25 BEI/ DE000HD5GBD5 /
21/06/2024 21:46:15 | Var.+1.720 | Denaro21:59:50 | Lettera21:59:50 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
169.610EUR | +1.02% | 169.590 Quantità in denaro: 200 |
169.690 Quantità in lettera: 200 |
BEIERSDORF AG O.N. | - - | 28/03/2025 | Call |
GlobeNewswire
16:17
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
GlobeNewswire
16:11
ROSEN, A TOP RANKED LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Importan...
GlobeNewswire
16:00
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
GlobeNewswire
15:50
ENPH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors ...
GlobeNewswire
15:48
PATH INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that UiPath, Inc. Investors with ...
GlobeNewswire
15:45
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
GlobeNewswire
15:00
ROSEN, A LEADING LAW FIRM, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Import...